Eiger BioPharmaceuticals (EIGR) Earnings
|
Expand Research on EIGR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -21.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/14/24 | Q423 | N/A | -$0.30 | N/A | N/A | $4.99M | N/A | N/A | N/A | ||
| 11/9/23 | Q323 | -$0.41 | -$0.31 | -$0.10 | $3.2M | $4.91M | N/A |  | | Details | |
8/14/23  |
Q223 | -$0.47 | -$0.39 | -$0.08 | $4.64M | $4.57M | N/A | | | Details | |
| 5/11/23 | Q123 | -$0.52 | -$0.42 | -$0.10 | $4.12M | $4.51M | N/A | | | Details | |
| 3/16/23 | Q422 | -$0.57 | -$0.53 | -$0.04 | $2.7M | $4.42M | N/A | | | Details | |
| 11/3/22 | Q322 | -$0.58 | -$0.48 | -$0.10 | $3.04M | $5.91M | N/A | | | Details | |
| 8/4/22 | Q222 | -$0.57 | -$0.58 | +$0.01 | $2.1M | $4.7M | N/A | | | Details | |
| 5/5/22 |
 |
Q122 | N/A | -$0.64 | N/A | N/A | $4.04M | N/A | N/A | N/A |
